Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02408653Not ApplicableCompleted

EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)

Role: collaborator

NCT02394639Not ApplicableWithdrawn

EEG@HOME (Phase 4 of the Project)

Role: collaborator

NCT02428348Not ApplicableTerminated

EEG@HOME (Phase 3b of the Project, Interviews)

Role: collaborator

NCT02408627Not ApplicableCompleted

EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)

Role: collaborator

NCT02408666Not ApplicableCompleted

EEG@HOME (Phase 1 of the Project)

Role: collaborator

All 5 trials loaded